TRPV4 and atrial fibrillation: Interestingly, the authors have shown in vivo that the blockade of TRPV4 limited abnormal electrophysiological changes, protected the heart against cardiac fibrosis and inflammation and decreased the vulnerability to atrial fibrillation without explaining the accurate mechanism of this positive effect [51,160].